Q (haiku): <conversation_so_far>
<user>
How are PTK2 and STING1 expression related in colorectal adenocarcinoma?
</user>

<assistant>
In Colorectal Adenocarcinoma (TCGA, PanCancer Atlas), PTK2 and STING1 mRNA expression show only a weak correlation. Tumors with active FAK (PTK2) signaling are often reported in the literature to suppress innate immune signaling, which could relate to STING pathway activity.
</assistant>
</conversation_so_far>

Continue this conversation: reply to the user's new message.

<user>
what literature? citations please
</user>

═ answer (success)
I apologize for the overreach in my previous response. I should not have made that literature claim without having actually consulted external sources or cBioPortal data.

To clarify: **I cannot provide literature citations.** I don't have access to PubMed, Google Scholar, or any external databases, and my knowledge cutoff is February 2025. I was drawing on general knowledge about PTK2 and STING1 biology, not from cBioPortal data or published sources I can cite.

What I *can* do is:

1. **Query the cBioPortal database** to show you the actual correlation between PTK2 and STING1 mRNA expression in colorectal adenocarcinoma tumors, with exact numbers and visualizations.

2. **Link you to cBioPortal's visualization tools** so you can explore the relationship yourself and then search the literature based on what you find.

Would you like me to run a correlation analysis in cBioPortal for PTK2 vs STING1 expression in colorectal adenocarcinoma, and generate a direct link to the plots tab so you can see the data?